Genomic landscape of Waldenström's macroglobulinemia

Genomic landscape of Waldenström's macroglobulinemia

Bibliographic Details
Main Authors:	Steven P. Treon, Zachary R. Hunter, Andrew R. Branagan, Jorge J. Castillo
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000228

Similar Items

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia
by: Jorge J. Castillo, et al.
Published: (2018-07-01)

What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy
by: Steven P. Treon, et al.
Published: (2017-11-01)

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy
by: Joshua N. Gustine, et al.
Published: (2021-06-01)

Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia
by: Jorge J. Castillo, et al.
Published: (2018-10-01)

IgA and IgG hypogammaglobulinemia in Waldenström’s macroglobulinemia
by: Zachary R. Hunter, et al.
Published: (2010-03-01)

A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib
by: Jorge J. Castillo, et al.
Published: (2022-08-01)

CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib
by: Josephine M. Vos, et al.
Published: (2017-11-01)

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
by: Dipti Talaulikar, et al.
Published: (2020-08-01)

Pathophysiology of Waldenström’s macroglobulinemia
by: Marvin J. Stone, et al.
Published: (2010-03-01)

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenström Macroglobulinemia
by: Amanda Kofides, et al.
Published: (2021-08-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials
by: Jorge J. Castillo, et al.
Published: (2020-06-01)

Diagnóstico presuntivo de la macroglobulinemia de Waldenström Presumptive diagnosis of the macroglobulinemia of Waldenström
by: Ana Dolores Izquierdo Calzado
Published: (2012-04-01)

Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia.
by: Juliette M Bouyssou, et al.
Published: (2018-01-01)

CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia
by: Joshua N. Gustine, et al.
Published: (2019-10-01)

Diagnosing and management of Waldenström macroglobulinemia
by: Monique C. Minnema, (Coordinating Author)
Published: (2019-06-01)

Molecular pathogenesis of Waldenström’s macroglobulinemia
by: Esteban Braggio, et al.
Published: (2012-09-01)

Current approach to Waldenström Macroglobulinemia
by: Gayathri Ravi, et al.
Published: (2022-01-01)

Cutaneous macroglobulinosis with Waldenström macroglobulinemia
by: Hussein M.M. Hassab-El-Naby, MD, et al.
Published: (2020-08-01)

A prognostic index predicting survival in transformed Waldenström macroglobulinemia
by: Eric Durot, et al.
Published: (2020-11-01)

Waldenstrom's Macroglobulinemia: A case report
by: Nejima Kolikkat, et al.
Published: (2020-01-01)

Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment
by: Eric Durot, et al.
Published: (2022-10-01)

CNS Vasculitis Associated with Waldenström Macroglobulinemia
by: Tanawan Riangwiwat, et al.
Published: (2016-01-01)

Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
by: Eugenio Morelli, et al.
Published: (2022-09-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

Waldenström's macroglobulinemia front line treatment
by: Alessandra Tedeschi, et al.
Published: (2019-06-01)

Treatment options for relapsed Waldenström's Macroglobulinemia
by: Alexander Grunenberg, et al.
Published: (2019-06-01)

Focal Segmental Glomerulosclerosis in Waldenström’s Macroglobulinemia
by: Akshee Batra, et al.
Published: (2020-01-01)

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
by: Wei Zhou, et al.
Published: (2012-04-01)

Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
by: Kratochvil David, et al.
Published: (2012-12-01)

Waldenstrom Macroglobulinemia Complicated with Hyperviscosity Syndrome
by: Narangerel Jigjidkhorol, et al.
Published: (2015-09-01)

A neuropatia na macroglobulinemia de Waldenström.
by: J Coimbra, et al.
Published: (1995-04-01)

Waldenstrom macroglobulinemia involving the superior rectus muscle
by: J.B. Hellman, et al.
Published: (2018-06-01)

MACROGLOBULINEMIA DE WALDENSTROM: ESTUDO DE CASO
by: C.A.S. Souza, et al.
Published: (2020-11-01)

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
by: Rayan Kaedbey, et al.
Published: (2022-09-01)

Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia
by: Kenichi Ito, et al.
Published: (2023-08-01)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
by: Nurhilal Büyükkurt, et al.
Published: (2023-06-01)

Severe nephritis as initial sign of Waldenström’s macroglobulinemia
by: Thomas Knoop, et al.
Published: (2019-12-01)

Localized retinal degeneration secondary to Waldenström's macroglobulinemia
by: Dhanashree Ratra, et al.
Published: (2017-01-01)

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia
by: Despina Fotiou, et al.
Published: (2022-01-01)